Oxford AI Predicts Heart Failure
Analysis based on 8 articles · First reported Apr 08, 2026 · Last updated Apr 09, 2026
The development of this AI tool by the University of Oxford, funded by the British Heart Foundation, is expected to significantly impact the healthcare and medical technology markets. It could lead to increased investment in AI-driven diagnostic tools, potentially boosting companies like Microbira that specialize in AI for healthcare, and improving the efficiency and outcomes of healthcare systems like the United Kingdom — National Health Service.
Scientists at the University of Oxford, led by Charalambos Antoniades and funded by the British Heart Foundation, have developed a new Artificial Intelligence tool capable of predicting a person's risk of heart failure up to five years before its onset. The tool analyzes routine cardiac CT scans to detect subtle, invisible changes in fat around the heart, indicating underlying heart muscle disease. Validated with 86% accuracy on data from 72,000 patients across nine United Kingdom — National Health Service trusts in England, the AI identifies high-risk individuals who are 20 times more likely to develop heart failure. This breakthrough is crucial for early diagnosis, allowing doctors to intervene sooner and potentially prevent severe heart damage. The United Kingdom — National Health Service plans to roll out this technology nationwide, aligning with its goal to become the most AI-enabled health system in the United Kingdom, and potentially reducing hospital pressures and improving patient longevity.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard